X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (65066) 65066
Book Review (13509) 13509
Newsletter (8411) 8411
Newspaper Article (6522) 6522
Publication (5007) 5007
Book Chapter (518) 518
Trade Publication Article (496) 496
Magazine Article (423) 423
Conference Proceeding (283) 283
Transcript (188) 188
Book / eBook (118) 118
Dissertation (86) 86
Web Resource (86) 86
Report (25) 25
Government Document (24) 24
Data Set (12) 12
Reference (7) 7
Paper (3) 3
Presentation (2) 2
Poster (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (49773) 49773
humans (47946) 47946
male (26129) 26129
female (24888) 24888
hepatitis (24771) 24771
middle aged (20229) 20229
adult (19991) 19991
hepatitis c (19712) 19712
gastroenterology & hepatology (17136) 17136
hepatitis c virus (17012) 17012
antiviral agents - therapeutic use (15126) 15126
interferon (13155) 13155
health aspects (12372) 12372
hepatitis c, chronic - drug therapy (11686) 11686
infection (9683) 9683
liver (9542) 9542
aged (9531) 9531
treatment outcome (9296) 9296
hepatitis b (9165) 9165
research (8688) 8688
drug therapy (8575) 8575
care and treatment (8569) 8569
infectious diseases (7827) 7827
infections (7633) 7633
therapy (7387) 7387
interferon-alpha - therapeutic use (7253) 7253
risk factors (7233) 7233
antiviral agents (7164) 7164
drug therapy, combination (7124) 7124
medical research (7019) 7019
virology (6877) 6877
liver diseases (6733) 6733
hepacivirus - genetics (6628) 6628
genotype (6523) 6523
ribavirin (6478) 6478
analysis (6406) 6406
hepatitis b virus (5786) 5786
virus diseases (5700) 5700
animals (5667) 5667
virus-infection (5636) 5636
biological response modifiers (5517) 5517
medicine, experimental (5451) 5451
ribavirin - therapeutic use (5451) 5451
patients (5311) 5311
immunology (5291) 5291
cirrhosis (4923) 4923
abridged index medicus (4877) 4877
liver cirrhosis (4818) 4818
pharmacology & pharmacy (4816) 4816
viruses (4812) 4812
adolescent (4703) 4703
hiv (4647) 4647
recombinant proteins (4645) 4645
hepatitis c - drug therapy (4591) 4591
hepatitis b, chronic - drug therapy (4510) 4510
prevalence (4456) 4456
antiviral agents - administration & dosage (4194) 4194
retrospective studies (4160) 4160
hepatocellular-carcinoma (4139) 4139
disease (4122) 4122
hepatitis c, chronic - complications (4109) 4109
viral load (4031) 4031
antiviral agents - adverse effects (4009) 4009
hepatology (3966) 3966
gastroenterology and hepatology (3912) 3912
genetic aspects (3900) 3900
hepatitis c, chronic - virology (3882) 3882
young adult (3860) 3860
hcv (3799) 3799
clinical trials (3765) 3765
liver cancer (3719) 3719
transplantation (3712) 3712
hepacivirus - drug effects (3641) 3641
medicine (3634) 3634
medicine, general & internal (3598) 3598
human immunodeficiency virus--hiv (3580) 3580
chronic hepatitis-c (3455) 3455
mortality (3402) 3402
pharmaceutical industry (3396) 3396
lamivudine (3380) 3380
medicine & public health (3348) 3348
hepatocellular carcinoma (3267) 3267
hepatitis b virus - genetics (3232) 3232
studies (3202) 3202
epidemiology (3175) 3175
time factors (3165) 3165
fibrosis (3142) 3142
liver - pathology (3130) 3130
digestive system diseases (3129) 3129
polyethylene glycols - therapeutic use (3092) 3092
oncology (3084) 3084
diagnosis (3081) 3081
genotype & phenotype (3075) 3075
cancer (3048) 3048
drugs (3044) 3044
antiviral agents - pharmacology (3028) 3028
prognosis (3005) 3005
liver transplantation (2932) 2932
hepatitis-c virus (2928) 2928
research article (2915) 2915
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (65) 65
Online Resources - Online (15) 15
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Scarborough Hospital - Online (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
UTL at Downsview - May be requested (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (78743) 78743
French (581) 581
Spanish (479) 479
German (444) 444
Japanese (331) 331
Chinese (298) 298
Russian (194) 194
Polish (150) 150
Korean (144) 144
Italian (105) 105
Hungarian (82) 82
Portuguese (54) 54
Turkish (39) 39
Croatian (37) 37
Czech (29) 29
Serbian (21) 21
Dutch (20) 20
Danish (18) 18
Swedish (14) 14
Romanian (13) 13
Norwegian (11) 11
Hebrew (8) 8
Slovak (7) 7
Ukrainian (5) 5
Persian (4) 4
Finnish (3) 3
Slovenian (3) 3
Bosnian (2) 2
Bulgarian (2) 2
Urdu (2) 2
Albanian (1) 1
Hindi (1) 1
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2015, Volume 386, Issue 10003, pp. 1537 - 1545
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 07/2015, Volume 163, Issue 1, pp. 1 - 13
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 07/2013, Volume 159, Issue 2, pp. 86 - 96
Background: Telaprevir (TVR) plus peginterferon-alpha 2a (PEG-IFN-alpha 2a) and ribavirin substantially increases treatment efficacy for genotype 1 chronic... 
Vertex pharmaceuticals and janssen pharmaceuticals | MEDICINE, GENERAL & INTERNAL | COINFECTED PATIENTS | MANAGEMENT | RECOMMENDATIONS | PREDICTORS | BOCEPREVIR | HCV | UPDATE | VIROLOGICAL RESPONSE | ASSOCIATION | INTERFERON PLUS RIBAVIRIN | HIV-1 | Recombinant Proteins - therapeutic use | Antiviral Agents - pharmacokinetics | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Polyethylene Glycols - adverse effects | Male | Recombinant Proteins - pharmacokinetics | Recombinant Proteins - adverse effects | Oligopeptides - adverse effects | Polyethylene Glycols - therapeutic use | Oligopeptides - therapeutic use | Ribavirin - pharmacokinetics | Interferon-alpha - pharmacokinetics | Adult | Anti-HIV Agents - therapeutic use | Female | Drug Therapy, Combination | Double-Blind Method | Antiviral Agents - therapeutic use | Oligopeptides - pharmacokinetics | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Polyethylene Glycols - pharmacokinetics | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Ribavirin - adverse effects | Antiviral Agents - adverse effects | HIV Infections - complications | Interferon-alpha - adverse effects | Antiviral agents | Patient outcomes | Dosage and administration | Drug therapy, Combination | Research | Hepatitis C | Drug therapy | HIV infection | Drugs | Clinical trials | Hepatitis | Side effects | Human immunodeficiency virus--HIV | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 11/2016, Volume 165, Issue 9, pp. 625 - 634
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2013, Volume 368, Issue 20, pp. 1878 - 1887
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2014, Volume 370, Issue 20, pp. 1879 - 1888
Journal Article